Robert Coffin, President & Chief R&D Officer at Replimune Group, Inc. (REPL), sold 74,978 shares at $40.05 ($3.0M) on 2021-06-29, disclosed to the SEC on 2021-06-30.
Open-market sale of $3.0M REPL by President & Chief R&D Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.04 | 14,663 | $587K | 19.6% |
| 2 | $40.04 | 14,663 | $587K | 19.6% |
| 3 | $40.05 | 22,826 | $914K | 30.4% |
| 4 | $40.05 | 22,826 | $914K | 30.4% |
| Total | $40.05 avg | 74,978 | $3.0M | 100% |
| Filing → |
| REPL | SELL | 2022-05-18 | $167K | — | Filing → |
| REPL | SELL | 2021-07-07 | $625K | — | Filing → |
| REPL | SELL | 2021-01-26 | $5.3M | — | Filing → |